欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cancer

货号 产品名 CAS号 信息
CSN19039 PD150606 179528-45-1 PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor (Ki values for ν and m-calpains are 0.21 and 0.37 μM respectively).
CSN19103 HMN-176 173529-10-7 HMN-176 is the active derivative of HMN-214 which can alter the cellular spatial orientation of Plk1.
CSN19078 WNK463 2012607-27-9 WNK463 is a potant With-No-Lysine (WNK) kinase inhibitor with IC50s of 5/1/6/9 nM for WNK1/2/3/4.
CSN19013 Pamapimod 449811-01-2 Pamapimod is a selective inhibitor of p38 mitogen-activated protein kinase. It inhibits p38α and p38β enzymatic activity with IC50 values of 0.014±0.002 and 0.48± 0.04 mM, respectively with no activity against p38delta or p38gamma isoforms.
CSN19098 Importazole 662163-81-7 Importazole is a small molecule inhibitor of the nuclear transport receptor importin-β.
CSN19020 A-804598 1125758-85-1 A-804598 is a competitive, and selective P2X7 receptor antagonist with IC50 of 10 nM, 9 nM and 11 nM in rat, mouse and human P2X7 receptors respectively.
CSN19072 CPI-637 1884712-47-3 CPI-637 is an efficient inhibitor of CBP/EP300 bromodomain with IC50 of 0.03 ± 0.01μM.
CSN19082 Eltanexor 1642300-52-4 KPT-8602 is a second-generation and oral acitve exportin-1 (XPO1/CRM1) inhibitor with IC50 of 20−211 nM in 10 AML cell lines.
CSN19043 PCC0208009 1668565-74-9 IDO-IN-2 is an IDO inhibitor with IC50 value of 68 nM and 160 nM in HeLa cell and HEK293 cell, respectively.
CSN19081 A-196 1982372-88-2 A-196 is a potent and selective inhibitor of SUV420H1 and SUV420H2 with IC50s of 25 and 144 nM respectively.
CSN19090 GNE-140 racemate 1802977-61-2 GNE-140 racemate is a LDHA inhibitor.
CSN19016 APS-2-79 2002381-25-9 APS-2-79 is an antagonist of MEK phosphorylation by RAF through direct binding of the KSR active site.
CSN19049 PF-04957325 1305115-80-3 PF-04957325 is a highly potent and selective PDE8 inhibitor, with IC50 values of 0.7 nM for PDE8A and less than 0.3 nM for PDE8B.
CSN19025 D-3263 HCl 1008763-54-9 D-3263 HCl is an orally bioavailable (transient receptor potential melastatin member 8) TRPM8 agonist.
CSN19064 N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-4-methoxybenzenesulfonamide 176708-42-2 KN-92 is an inactive derivative of KN-93. KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).
CSN19069 GSK2983559 active metabolite 1423186-80-4 RIP2 kinase inhibitor 1 is a receptor interacting protein-2 (RIP2) kinase inhibitor.
CSN19054 IDO-IN-3 2070018-30-1 IDO-IN-3 is a potent IDO inhibitor.
CSN19033 Monepantel 887148-69-8 Monepantel is organic anthelmintic, and acts as a positive allosteric modulator of a nematode-specific clade of nicotinic acetylcholine receptor (nAChR) subunits.
CSN19015 Dehydrocorydaline chloride 10605-03-5 Dehydrocorydaline chloride is an alkaloidal that has anti-inflammatory and anti-cancer activities.
CSN19083 Eltanexor Z-isomer 1642300-78-4 KPT-8602 Z-isomer is an isomer of KPT-8602, which is highly specific for XPO1 inhibition and demonstrates potent anti-leukemic activity.
CSN19068 RIP2 kinase inhibitor 2 1581270-11-2 RIP2 kinase inhibitor 2 is a receptor interacting protein-2 (RIP2) kinase inhibitor.
CSN19017 Ravoxertinib HCl 2070009-58-2 GDC-0994 HCl is highly selective for ERK1 and ERK2, with biochemical potency of 1.1 nM and 0.3 nM, respectively.
CSN19066 (+)-DHMEQ 287194-41-6 (+)-DHMEQ, the distomer of DHMEQ, is an inhibitor of NF-κB.
CSN19060 Sophoflavescenol 216450-65-6 Sophoflavescenol is a prenylated flavonol, which shows great inhibitory activity with IC50 of 13 nM against phosphodiesterase 5 (PDE5), and also inhibits RLAR, HRAR, AGE, BACE1, AChE and BChE with IC50s of 0.30 μM, 0.17 μM, 17.89 μg/mL, 10.98 μM, 8.37 μM and 8.21 μM, respectively.
CSN19056 AZ876 898800-26-5 AZ876 is a high-affinity LXR agonist.
CSN19063 N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide phosphate 1913269-12-1 KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).
CSN19120 BBT594 882405-89-2 BBT594 is a potentreceptor tyrosine kinase RET inhibitor, used for cancer treatment.
CSN19124 PIM-447 2HCl 1820565-69-2 PIM-447 2HCl is pan-PIM kinase inhibitor, including Moloney Murine Leukemia (PIM)1, 2, and 3 Kinase.
CSN19052 Seviteronel (R enantiomer) 1375603-38-5 VT-464 R-enantiomer is the R-enantiomer with unknown activity of VT-464, which is a potent CYP17 lyase inhibitor (h-Lyase IC50=69 nM).
CSN19037 TAPI-2 187034-31-7 TAPI-2 is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC50 of 20±10 μM for MMP.
CSN19042 SYP-5 1384268-04-5 SYP-5 is a HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.
CSN19119 Endoxifen (E-isomer) 114828-90-9 Endoxifen E-isomer is the E-isomer of (Z)-Endoxifen, which is an active metabolite generated via actions of CYP3A4/5 and CYP2D6, is a more potent selective estrogen receptor modulator (SERM) than Tamoxifen.
CSN19136 Sotetsuflavone 2608-21-1 Sotetsuflavone is a potent inhibitor of DENV-NS5 RdRp (Dengue virus NS5 RNA-dependent RNA polymerase) with an IC50 of 0.16 μM, is the most active compound of this series .
CSN19109 PSI-697 851546-61-7 PSI-697is a P-selectin inhibitor.
CSN19130 NSC 601980 2070018-27-6 NSC601980 shows antitumor activity in the yeast screening experiment, which can inhibit cell proliferation in the COLO 205 and HT29 with Log GI 50 of -6.6 and -6.9 respectively.
CSN19023 ML204 HCl 2070015-10-8 ML204 HCl is a potent, selective TRPC4 channel inhibitor with IC50 of 0.96 μM.
CSN19046 FAS-IN-1 Tosylate N/A FAS-IN-1 tosylate is a potent inhibitor of fatty acid synthase (FAS) with an IC50 of 10 nM.
CSN19074 RK-33 1070773-09-9 RK-33 is a first-in-class small molecule inhibitor of DDX3 (a RNA helicase) and causes G1 cell cycle arrest, induces apoptosis, and promotes radiation sensitization in DDX3-overexpressing cells.
CSN19057 (R,S)-Ivosidenib 2070009-31-1 (R,S)-Ivosidenib is an inhibitor of isocitrate dehydrogenase (IDH1).
CSN19094 JPH203 1037592-40-7 JPH203 is a potent and selective L-type amino acid transporter 1 (LAT1) inhibitor that can be used for cancer research.
CSN19075 CCF642 346640-08-2 CCF642 is a PDI-inhibiting compound with antimyeloma activity.
CSN19050 GNE-617 HCl 2070014-99-0 GNE-617 HCl is a specific NAMPT inhibitor that inhibits the biochemical activity of NAMPT with an IC50 of 5 nM and exhibits efficacy in xenograft models of cancer.
CSN19051 AP-III-a4 HCl 2070014-95-6 AP-III-a4 HCl is a small molecule which is the first, nonsubstrate analogue that directly binds to enolase and inhibits its activity (IC50=0.576 uM) and inhibit cancer cell metastasis in vivo.
CSN19012 HO-3867 1172133-28-6 HO-3867 selectively inhibits the phosphorylation and transcription of STAT3. It is an analog of curcumin.
CSN19059 Mardepodect HCl 2070014-78-5 PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with > 1000-fold selectivity over the PDE.
CSN19079 ML390 2029049-79-2 ML390 is a human DHODH inhibitor that induces differentiation in acute myeloid leukemia.
CSN19061 AZD3839 1227163-84-9 AZD3839 is an inhibitor of BACE1 with IC50 of 23.6 uM.
CSN19055 4-((4'-(aminomethyl)-[1,1'-biphenyl]-3-yl)oxy)pyrimidine-2-carbonitrile hydrochloride 2197053-49-7 Cysteine protease inhibitor HCl is an inhibitor of cysteine protease.
<< PREV 7 8 9 10 11 12 13 14 15 NEXT >>
联系
我们